Kineta has completed enrollment in the monotherapy cohorts of the Phase 1 VISTA-101 clinical trial. The ongoing Phase 1 study is now enrolling patients into cohorts evaluating KVA12123 in combination ...

Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...

Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in ...

ALAMEDA, Calif. & RAHWAY, N.J., October 14, 2024--Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the companies have ...

Around 7:45 p.m. on Oct. 15, Northeast Corridor Train 3663 struck and killed the man after the train left Penn Station New ...

M.R.W. is on the speaker’s bureau for Merck and has acted as a consultant for Merck. L.L. has acted as a consultant for Merck, Novartis, and Bayer, and has received grants from Pfizer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A man was fatally hit by an NJ Transit train on Tuesday night in Rahway. At around 7:45 p.m., Northeast Corridor train 3963 — ...

NJ.com subscribers can also get free print-quality digital downloads of any images in this gallery. Note: Because we are trying to make these galleries available for viewing as quickly as possible ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...